LCTX Competitors & Alternatives

Compare Lineage Cell Therapeutics Inc with similar stocks in the same industry

Biotechnology

LCTX

Main Stock
$0.77
-5.87%
Tradestie Score
56
Market Cap
$385.92M
Revenue Growth
-61.0%
Analyst Upside
+612.5%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Cell Therapy
Competitive Moat: None
Core Technology Stack: induced pluripotent stem cells, directed cell differentiation
Major Customers 3
clinical trial sites academic medical centers biopharma partners
Critical Suppliers 3
GMP manufacturing partners reagent suppliers cell culture media providers
Direct Ecosystem Rivals 3

Top Competitors

215 stocks in Biotechnology
Company Price Market Cap P/E Score Action
VTYX Ventyx Biosciences, Inc. Common Stock
$14.00
+0.14%
$256.71M - 51 Compare
CYPH CYPH
$1.41
-18.02%
$256.35M 0.8 49 Compare
SLN Silence Therapeutics Plc American Depository Share
$19.81
$240.89M - 46 Compare
OABI OmniAb, Inc. Common Stock
$4.66
-7.36%
$231.77M - 46 Compare
SGMT Sagimet Biosciences Inc. Series A Common Stock
$9.08
-5.61%
$227.00M - 45 Compare
SLS SELLAS Life Sciences Group, Inc. Common Stock
$13.66
-8.08%
$211.22M - 36 Compare
ACRS Aclaris Therapeutics, Inc.
$3.44
-1.71%
$202.58M - 42 Compare
CBIO Crescent Biopharma, Inc. Common Stock
$13.00
+0.70%
$199.71M - 49 Compare
FBRX Forte Biosciences, Inc. Common Stock
$76.99
+0.03%
$180.53M - 54 Compare
ACHV Achieve Life Sciences, Inc.
$6.78
+0.89%
$158.43M - 56 Compare

Data updated: Nov 20, 2026 | Industry: Biotechnology (SIC 2836)

215 stocks in this industry